Walgreens used PWNHealth’s network of physicians to order tests for customers who scheduled appointments using Walgreens’ website, according to a court document.

Retail pharmacy giant Walgreen Co must pay more than $987 million to satisfy an arbitration award won by telemedicine provider PWNHealth, a federal judge in Delaware ruled on Monday.

Grail, which makes a blood test for cancer, said a vendor’s software issue caused inaccurate letters to be sent to about 400 customers last month.

More than 400 Grail patients incorrectly told they may have cancer Life assurance customers pause review relationship with early-detection biotech.

The settlement comes just weeks after a federal judge upheld a $987 million arbitration award that Walgreens and virtual care company PWNHealth, now doing business as Everly Health, had been ...

Grail said a software glitch related to their telemedicine vendor, PWNHealth, caused them to send letters to about 400 patients saying they might have cancer when they do not.

PWNHealth, which does business as Everly Health Solutions, separately asked the judge to affirm the arbitration award, according to court filings unsealed on Tuesday.

Walgreens contracted with PWNHealth to use its physician network to order COVID-19 tests that customers requested via a website jointly designed by Walgreens and PWNHealth, according to Everly ...

PWNHealth, which is a subsidiary of Everlywell, a digital health company, is an independent telemedicine vendor which reviews Galleri test requests, prescribes the test and delivers results to ...

Hundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday.